Relypsa IPO Research Information

Relypsa IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Relypsa, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Relypsa	RLYP -	$16.00-$19.00	$11.00	$12.59	6.9 million	11/15/2013
Underwriter(s): Morgan Stanley, BofA Merrill Lynch
Co-Manager(s): Stifel, Cowen & Co., Wedbush PacGrow Life Sciences
Industry: Health Care
Filing(s): Filed 2013-09-27

Relypsa Quote & Chart - Click for current quote - RLYP

About Relypsa (adapted from Relypsa prospectus):
They are a pharmaceutical company focused on the development and commercialization of non-absorbed polymeric drugs to treat disorders in the areas of renal, cardiovascular and metabolic diseases.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "RLYP" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.